Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 3906108, 9 pages
http://dx.doi.org/10.1155/2016/3906108
Research Article

Anti-Inflammatory Effects of TRAF-Interacting Protein in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

1Department of Orthopedic Trauma, Affiliated Hospital of Chengde Medical University, Chengde, Hebei 06700, China
2Department of Ophthalmology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei 06700, China
3Department of Spinal Surgery, Affiliated Hospital of Chengde Medical University, Chengde, Hebei 06700, China
4Department of Emergency, Affiliated Hospital of Chengde Medical University, Chengde, Hebei 06700, China
5Department of Gynaecology and Obstetrics, Maternal and Child Health Care Hospital of Longhua County, Chengde, Hebei 068150, China

Received 27 April 2016; Accepted 4 October 2016

Academic Editor: Luca Cantarini

Copyright © 2016 Qing-Zhu Kong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. B. McInnes and G. Schett, “The pathogenesis of rheumatoid arthritis,” The New England Journal of Medicine, vol. 365, no. 23, pp. 2205–2219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Juarez, A. Filer, and C. D. Buckley, “Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer,” Swiss Medical Weekly, vol. 142, Article ID w13529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. G. S. Firestein, “Evolving concepts of rheumatoid arthritis,” Nature, vol. 423, no. 6937, pp. 356–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. K. Chang, Z. Gu, and M. B. Brenner, “Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11,” Immunological Reviews, vol. 233, no. 1, pp. 256–266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Bartok and G. S. Firestein, “Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis,” Immunological Reviews, vol. 233, no. 1, pp. 233–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Yoshioka, E. Kozawa, H. Urakawa et al., “Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts,” Arthritis and Rheumatism, vol. 65, no. 5, pp. 1160–1170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-E. Huh, B.-K. Seo, Y.-C. Park et al., “WIN-34B, a new herbal medicine, inhibits the inflammatory response by inactivating IκB-α phosphorylation and mitogen activated protein kinase pathways in fibroblast-like synoviocytes,” Journal of Ethnopharmacology, vol. 143, no. 3, pp. 779–786, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Xu, X. Feng, W. Tan et al., “IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients,” Arthritis Research and Therapy, vol. 15, no. 5, article R170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Tian, J.-W. Chen, J.-S. Gao, L. Li, and X. Xie, “Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway,” Rheumatology International, vol. 33, no. 7, pp. 1829–1835, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Fujisawa, H. Asahara, K. Okamoto et al., “Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice,” The Journal of Clinical Investigation, vol. 98, no. 2, pp. 271–278, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. A. V. Miagkov, D. V. Kovalenko, C. E. Bnown et al., “NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 23, pp. 13859–13864, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Tomita, E. Takeuchi, N. Tomita et al., “Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligodeoxynucleotides as a gene therapy,” Arthritis and Rheumatism, vol. 42, no. 12, pp. 2532–2542, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Lattuada, R. Gualtierotti, K. Crotta et al., “Smac127 has proapoptotic and anti-inflammatory effects on rheumatoid arthritis fibroblast-like synoviocytes,” Mediators of Inflammation, vol. 2016, Article ID 6905678, 9 pages, 2016. View at Publisher · View at Google Scholar
  14. G. Yin, Y. Wang, X. M. Cen, M. Yang, Y. Liang, and Q. B. Xie, “Lipid peroxidation-mediated inflammation promotes cell apoptosis through activation of NF-κB pathway in rheumatoid arthritis synovial cells,” Mediators of Inflammation, vol. 2015, Article ID 460310, 10 pages, 2015. View at Publisher · View at Google Scholar
  15. A. Besse, A. D. Campos, W. K. Webster, and B. G. Darnay, “TRAF-interacting protein (TRIP) is a RING-dependent ubiquitin ligase,” Biochemical and Biophysical Research Communications, vol. 359, no. 3, pp. 660–664, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Regamey, D. Hohl, J. W. Liu et al., “The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor κB activation by tumor necrosis factor,” Journal of Experimental Medicine, vol. 198, no. 12, pp. 1959–1964, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Zhang, L. Wang, X. Zhao et al., “TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1,” Journal of Experimental Medicine, vol. 209, no. 10, pp. 1703–1711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Zhou and R. L. Geahlen, “The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells,” Oncogene, vol. 28, no. 10, pp. 1348–1356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Almeida, S. Ryser, M. Obarzanek-Fojt, D. Hohl, and M. Huber, “The TRAF-interacting protein (TRIP) Is a regulator of keratinocyte proliferation,” Journal of Investigative Dermatology, vol. 131, no. 2, pp. 349–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Yang, S. Trent, V. Ionescu-Tiba et al., “Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression,” Cancer Research, vol. 66, no. 24, pp. 11649–11658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Chapard, D. Hohl, and M. Huber, “The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis,” Oncotarget, vol. 6, no. 25, pp. 20933–20945, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Aletaha, T. Neogi, A. J. Silman et al., “2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative,” Arthritis & Rheumatology, vol. 62, no. 9, pp. 2569–2581, 2010. View at Publisher · View at Google Scholar
  23. J. J. Zhou, J. D. Ma, Y. Q. Mo et al., “Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation,” Arthritis Research & Therapy, vol. 16, no. 5, article 472, 2014. View at Publisher · View at Google Scholar
  24. L. Zhang, J. Luo, H. Wen, T. Zhang, X. Zuo, and X. Li, “MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-κB,” International Immunopharmacology, vol. 30, pp. 69–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kawakami, T. Nakashima, H. Sakai et al., “Regulation of synovial cell apoptosis by proteasome inhibitor,” Arthritis and Rheumatism, vol. 42, no. 11, pp. 2440–2448, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Xue, Z. Zhou, X. Lei et al., “TRIM38 negatively regulates TLR3-mediated IFN-β signaling by targeting TRIF for degradation,” PLoS ONE, vol. 7, no. 10, Article ID e46825, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Y. Lee, S. Y. Lee, and Y. Choi, “TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation,” Journal of Experimental Medicine, vol. 185, no. 7, pp. 1275–1285, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. D. R. Hammaker, D. L. Boyle, M. Chabaud-Riou, and G. S. Firestein, “Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis,” The Journal of Immunology, vol. 172, no. 3, pp. 1612–1618, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Wang, G.-H. Su, F. Zhang, J.-X. Chu, and Y.-S. Wang, “Cyclic GMP-AMP synthase is required for cell proliferation and inflammatory responses in rheumatoid arthritis synoviocytes,” Mediators of Inflammation, vol. 2015, Article ID 192329, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Bottini and G. S. Firestein, “Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors,” Nature Reviews Rheumatology, vol. 9, no. 1, pp. 24–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Dasuri, M. Antonovici, K. Chen et al., “The synovial proteome: analysis of fibroblast-like synoviocytes,” Arthritis Research & Therapy, vol. 6, no. 2, pp. R161–R168, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Chen, B. Casali, L. Pattacini, L. Boiardi, and C. Salvarani, “Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction,” Journal of Rheumatology, vol. 33, no. 6, pp. 1061–1068, 2006. View at Google Scholar · View at Scopus
  33. J. A. Roman-Blas and S. A. Jimenez, “NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis,” Osteoarthritis and Cartilage, vol. 14, no. 9, pp. 839–848, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” The Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. J.-H. Wang, K.-S. Shih, J.-P. Liou et al., “Anti-arthritic effects of magnolol in human interleukin 1β-stimulated fibroblast-like synoviocytes and in a rat arthritis model,” PLoS ONE, vol. 7, no. 2, Article ID e31368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Torices, L. Alvarez-Rodŕguez, L. Grande et al., “A truncated variant of ASCC1, a novel inhibitor of NF-κB, is associated with disease severity in patients with rheumatoid arthritis,” The Journal of Immunology, vol. 195, no. 11, pp. 5415–5420, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Gonzalez-Juanatey, T. R. Vazquez-Rodriguez, J. A. Miranda-Filloy et al., “Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy,” Mediators of Inflammation, vol. 2012, Article ID 674265, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. S. K. Raghav, B. Gupta, C. Agrawal, V. P. Chaturvedi, and H. R. Das, “Expression of TNF-α and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients,” Mediators of Inflammation, vol. 2006, Article ID 12682, 5 pages, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Fan, Y. Yu, Y. Shi et al., “Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation,” The Journal of Biological Chemistry, vol. 285, no. 8, pp. 5347–5360, 2010. View at Google Scholar · View at Scopus
  40. R. Mao, Y. Fan, Y. Mou, H. Zhang, S. Fu, and J. Yang, “TAK1 lysine 158 is required for TGF-β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation,” Cellular Signalling, vol. 23, no. 1, pp. 222–227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Fan, Y. Yu, R. Mao, H. Zhang, and J. Yang, “TAK1 Lys-158 but not Lys-209 is required for IL-1β-induced Lys63-linked TAK1 polyubiquitination and IKK/NF-κB activation,” Cellular Signalling, vol. 23, no. 4, pp. 660–665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. Y.-H. Fan, Y. Yu, R.-F. Mao et al., “USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation,” Cell Death and Differentiation, vol. 18, no. 10, pp. 1547–1560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Yamazaki, J. Gohda, A. Kanayama et al., “Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling,” Science Signaling, vol. 2, no. 93, p. ra66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Sorrentino, N. Thakur, S. Grimsby et al., “The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner,” Nature Cell Biology, vol. 10, no. 10, pp. 1199–1207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Fan, Y. Shi, S. Liu et al., “Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation,” Cellular Signalling, vol. 24, no. 7, pp. 1381–1389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Ahmed, M. Zeng, I. Sinha et al., “The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation,” Nature Immunology, vol. 12, no. 12, pp. 1176–1183, 2011. View at Publisher · View at Google Scholar · View at Scopus